Ban advertising and promotion of tobacco products, tobacco company brands, and the use of tobacco at expos.
832
世卫组织欢迎瑞士批准第二项埃博拉疫苗试验
WHO welcomes approval of a second Ebola vaccine trial in Switzerland
833
2014年11月6日 | 媒体说明
6 November 2014 | Note for Media
834
世卫组织欢迎瑞士药品管理局（瑞士治疗产品监管当局）利用实验性埃博拉疫苗在瑞士开展第二项试验。
WHO welcomes approval by Swissmedic, the Swiss regulatory authority for therapeutic products, of a second Swiss trial of an experimental Ebola vaccine.
835
这项试验将由日内瓦大学医院牵头负责。
The trial will be led by the University Hospitals of Geneva (HUG).
836
如判定具有安全性，将最早于2015年1月在非洲国家开展更大规模的试验。
If judged safe, larger scale trials will be taken to African countries as early as January 2015.
837
这一批准就意味着该疫苗将在日内瓦约115名志愿者身上进行测试。
This trial approval means that the vaccine will be tested on approximately 115 volunteers in Geneva.
The trial, which is receiving support from WHO, is the latest in a series of trials involving 2 different candidate Ebola vaccines that are ongoing in Switzerland, Mali, the United Kingdom, and the United States.
839
疫苗情况
About the vaccine
840
这一试验性VSV-ZEBOV疫苗是由加拿大公共卫生署的科学家开发出来的。
The experimental VSV-ZEBOV vaccine has been developed by scientists at the Public Health Agency of Canada .